Gonadotropin expression is precisely regulated within the hypothalamic-pituitary-gonadal axis through the complex interaction of neuropeptides, gonadal steroids. and both gonadal-and pituitary-derived peptides. In the anterior pituitary gland, the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) modulates gonadotropin biosynthesis and secretion, acting both alone and in conjunction with GnRH. Steroid hormone feedback also influences gonadotropin expression via both direct and indirect mechanisms. Evidence from nonpituitary tissues suggests that PACAP may be a target for gonadal steroid regulation. In the present study, we show that androgen markedly stimulates rat (r) PACAP promoterreporter activity in the LβT2 mature mouse gonadotrope cell line. 5′-Serial deletion analysis of reporter constructs identifies 2
published on The Endocrine Society's Journals Online web site at http://mend.endojournals.org. PCR products were separated on 1% agarose gel and photographed using a ChemiImager 4400 Imaging System (Alpha Innotech, Santa Clara, California). The identity of the amplified AR bands for LβT2 cells and mouse pituitary were confirmed by purification and sequencing of the PCR product.
Western blot analysis
LβT2 cells (10 × 10 6 ) were plated overnight in 100-mm dishes in high-glucose DMEM supplemented with 10% (vol/vol) FBS, 1 mM sodium pyruvate, and 1% (vol/vol) penicillin/ streptomycin, cultured an additional 24 hours in phenol red-free Opti-MEM (Gibco/Life Technologies) supplemented with 5% charcoal:dextran-stripped FBS, and then treated with 100 nM DHT or vehicle in plain phenol red-free Opti-MEM for 6-48 hours, as indicated. Nuclear extracts were prepared using the method described by Andrews and Faller (44). Mouse testis tissue extract was prepared from snap-frozen, pulverized adult C57BL/6 testis in radioimmunoprecipitation assay (RIPA) buffer containing protease and phosphatase inhibitor cocktails. Protein was quantitated with the BCA Protein Assay Kit (Thermo Scientific Pierce, Rockford, Illinois), separated on a 10% SDS-PAGE gel and transferred onto Immobilon-P membrane (Millipore Corp, Billerica, Massachusetts). After blocking, the membrane was probed with a 1:250 dilution of anti-AR antibody (PG21, Millipore) followed by a 1:20 000 dilution of anti-rabbit HRPO secondary antibody (NA34VS, GE HealthCare, Pittsburgh, Pennsylvania). Bound secondary antibody was visualized using the SuperSignal West Dura chemiluminescent substrate kit (Thermo Scientific Pierce) and exposure to autoradiography film. The membrane was then stripped with Restore Western Blot Stripping Buffer (Thermo Scientific) and reprobed with 1:5000 anti-α-tubulin (DM1A, Sigma-Aldrich) followed by antimouse-HRPO (NA931VS, GE HealthCare) and visualized with SuperSignal West Pico substrate kit (Thermo Scientific Pierce).
EMSA
LβT2 cells were grown in 100-mm culture dishes and treated with 100 nM DHT or vehicle for 48 hours as described for Western blot analysis. Cells were harvested by scraping in cold PBS containing 0.6 mM EDTA, the resulting sample was pelleted, and nuclear proteins were extracted according to the method of Andrews and Faller (44). Recombinant full-length AR was overexpressed in Sf9 insect cells using a human Flag-AR baculovirus construct graciously provided by Dr. Elizabeth M. Wilson at The University of Colorado. Production of recombinant hFlag-AR was carried out at the University of Colorado Cancer Center Protein Production/MoAb/Tissue Culture core facility. Sf9 cell infection, growth conditions, and subsequent generation of whole-cell extracts were carried out as previously described (35). Double-stranded oligonucleotides were end labeled with [γ-32 P]ATP and purified over a Quick Spin G-25 Sephadex Column (Roche Applied Science, Indianapolis, Indiana). Oligonucleotide probe sequences are provided in Supplemental Table 1 . Sequence for the consensus HRE probe has been previously reported (35). Nuclear protein or hFlag-AR extracts were incubated with 60 000 cpm of probe in DNA-binding buffer containing 10 mM Tris-HCl, pH 7.5, 40 mM KCl, 0.2 mM EDTA, 10 mM DTT, 10% (vol/vol) glycerol, 0.8 mg/ml BSA, and 50 μg/ml poly[d(I-C)] for 1 hour prior to resolution electrophoresis on a 5% nondenaturing polyacrylamide gel in 0.5× Tris-borate-EDTA buffer. Where appropriate, 2 μL of antisera were added for the final 30 minutes of incubation and are the same as listed for ChIP. The gel was dried and subjected to autoradiography.
Transient transfection of cell lines
LβT2 cells (2 × 10 5 )/well were plated overnight in 24-well plates, rinsed in HBSS, and cultured an additional 24 hours in phenol red-free Opti-MEM with 5% charcoal:dextran-stripped FBS, and then transfected approximately 48 hours after plating with 200 ng/well luciferase reporter vector, 100 ng pSG5-AR, and 2.5 ng/well pGL4.74 expressing Renilla luciferase (Promega Corp., Madison, Wisconsin) as an internal control using Fugene 6 (Roche) at a 3:1 (microliters/μg of DNA) ratio in fresh 5% stripped fetal calf serum phenol red-free-Opti-MEM according to manufacturer's instructions. The cells were treated the following day with DHT (100 nM or as indicated) or vehicle for 24 hours. Cell extracts were prepared and luciferase activity was assessed with the Promega Dual-Luciferase Reporter Assay System according to manufacturer's instructions using a Berthold Detection Systems luminometer (Pforzheim, Germany). Relative light units (RLU) for luciferase in each sample were corrected against RLU of a cotransfected Renilla luciferase reporter. The fold-change following androgen treatment was then calculated relative to the matching vehicle-treated control. The foldinduction of deletion or mutant promoter-reporter constructs was expressed as the percent activity relative to the foldinduction of the full-length or wild-type control construct, as applicable.
Plasmids
The rPACAP promoter-pGL3 luciferase reporter constructs have been previously described (39). Additional 5′-deletion constructs and site-directed mutations were generated by PCR or using the Stratagene QuikChange II Site-Directed Mutagenesis Kit, respectively (La Jolla, California). Sequences of mutated residues are identical to those reported for EMSA probes in Supplemental AR expression is regulated at multiple levels with posttranscriptional regulation occurring independent of, and oftentimes opposite to, changes in mRNA levels (53, 54). To confirm that our LβT2 cells were expressing AR, we first used RT-PCR to detect AR mRNA. As shown in Figure 1A , AR transcripts were readily detected in mouse ovary, anterior pituitary, and untreated LβT2 cells. AR mRNA levels were not
affected by exposure to androgen (data not shown). This result is consistent with previous findings for LβT2 cells (47).
A variety of studies have demonstrated that androgen treatment leads to an overall increase of AR within the nucleus due to a decrease in the rate of AR degradation and conformational changes that promote dimerization, translocation into the nucleus, and high-affinity DNA binding (53, 55-58). Therefore, we reasoned that AR protein expression in LβT2 cell nuclear extracts would be highest following androgen treatment. We prepared nuclear extracts from cells cultured for 6, 12, 24, or 48 hours with 100 nM DHT vs vehicle control. After repeatedly failing to detect AR with conventional substrates, we were ultimately successful in detecting AR by Western blot, which depended on the use of highly sensitive, extended duration chemiluminescent substrates, an indication that the overall level of AR in LβT2 cells is extremely low. Western blot analysis ( Figure 1B ) revealed that AR (110 kDa) was faintly detectable in nuclear extracts of non-androgen-treated cells at 6 hours, gradually declining and becoming undetectable at later time points. In contrast, AR was detected at 6 hours in nuclear extracts from DHT-treated cells and increased in abundance over the 48-hour treatment period, indicating that LβT2 cells do, indeed, retain the ability to respond to exogenous androgen treatment, at least in terms of increasing nuclear AR.
We next wished to determine whether the AR could bind a hormone response cis-element on DNA. Nuclear extracts of DHT-treated vs untreated LβT2 cells were tested using EMSA ( Figure 1C ). Multiple binding complexes were formed when LβT2 nuclear extracts were incubated with a radiolabeled probe containing a consensus HRE (described in Reference 35 and Supplemental Table 1 ). Coincubation with an AR-specific antibody produced an AR-specific supershift in the nuclear extract of DHT-treated but not control-treated cells (compare Figure 1C, lanes 9 and 12) . As a positive control, whole-cell extract from Sf9 insect cells containing a baculovirus expressed human Flag-tagged AR (Flag-AR) was found to bind robustly to the same consensus HRE ( Figure 1C, lanes 3-5) . As with Western blot, extended exposure times were necessary to detect the LβT2 AR-specific signal on EMSA, also suggesting that AR levels in LβT2 cells are quite low.
Androgen stimulates PACAP transcription in gonadotropes
Gonadally derived androgens are well-described modulators of gonadotropin biosynthesis through feedback mechanisms (59). We hypothesized that androgen may also regulate the synthesis of PACAP within gonadotropes. EMSA was used to assess the ability of AR to bind the wild-type and mutated HRE DNA sequences. To maximize the AR signal, we elected to perform the gel-shift assays using baculovirusexpressed recombinant AR. As shown in Figure 5B Oligo probes carrying the same mutations in HRE1 and HRE2 or the double mutant as used in the aforementioned transfection analysis were also tested for AR binding by EMSA ( Figure 5B) . Mutation of HRE1 nearly eliminated AR binding ( Figure 5B , lanes 5 and 6) even in the presence of anti-AR antibody whereas mutation of HRE2 had little effect ( Figure 5B, lanes 7 and 8) . Mutation of HRE1+2 together ( Figure 5B, lanes 9 and 10) was similar to the mutation of HRE1 alone. These findings are consistent with our transfection data wherein the greater loss of AR binding paralleled the loss of ability to stimulate promoter transcriptional activity.
AR binding at HRE3 was tested with another oligonucleotide probe spanning −825 to −791 ( Figure 5C ). An AR-specific supershift was observed for high-molecular weight proteinnucleotide complexes in extracts containing overexpressed AR but not in mock-infected cell extracts ( Figure 5C , lane 5 vs lane 2). Mutation of HRE3 eliminated AR binding ( Figure 5C , lanes 7 and 8) on this oligonucleotide. This result was surprising because the identical mutation had no effect on androgen responsiveness in transient transfection ( Figure 5A ). The triple mutation of HRE1+2+3 was not tested on EMSA due to the extreme length of the probe that would be necessary. Therefore, although AR seems capable of binding the HRE3 promoter element, HRE3 alone is inadequate to confer androgen responsiveness. We cannot rule out the possibility of a cooperative effect with HRE1 and HRE2 but the transfection data suggest that HRE3 does not confer any significant additional effect over that of HRE1+2 alone. cells (35, 36, 52, 68, 69) . In the studies reported here, the rPACAP promoter was robustly activated by androgen in the context of the immortalized LβT2 gonadotrope, with activation that is dependent on the presence of AR.
To our knowledge, our study is the first to directly examine androgen regulation of PACAP gene expression; however, our findings are consistent with the few prior studies that have examined PACAP expression in males, wherein androgen levels were altered through effects of castration with or without testosterone replacement. Castration of 2-month-old rats dramatically reduced PACAP peptide in all brain areas, including the pituitary, within the first week after castration (70), suggesting that androgen or other gonadal factors positively regulated PACAP expression. Interestingly, the levels of PACAP in the castrated animals gradually recovered, and pituitary PACAP concentrations were significantly higher than initial levels within 4 months after castration. Based on prior findings by our laboratory that GnRH induces PACAP expression (39), we could hypothesize that this increase resulted from the rise in hypothalamic GnRH levels that follow castration. It must be noted that castration produces complex and wide-ranging effects within the HPG axis. For example, gain or loss of hormones or other gonadal factors such as inhibin affects GnRH production in the hypothalamus and directly alters gonadotropin expression in the pituitary. 
